Bicon Pharmaceutical is a large-scale pharmaceutical enterprise group with integrated businesses covering pharmaceutical raw materials, Chinese patent medicines, chemicals, biological agents, vaccine R&D, production and marketing.
The production base of Bicon Pharmaceutical covers an area of 7.33 hectares and has the largest monomer workshop in Asia that meets the good manufacturing practice (GMP) standard. It has a sterilization space of 32,500 square meters and 15 production lines of tablets, capsules, soft capsules, granules, ointment, oral solution, syrup, large-volume injections, small-volume injections, and other products. The annual production capacity of the base is more than RMB 6 billion.
The company also operates a herbal medicine extraction workshop of 5,000 square meters with an annual extraction capacity of 8,000 tons.
Bicon Pharmaceutical was founded in 1997 and became a foreign-owned enterprise owned by Hong Kong Bicon International with a registered capital of RMB 937 million.
Funding Rounds (2) - $250MUpdate
Xi'an Keji Road E Yang International Building 10F
High-tech Zone, Shaanxi